Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database

Neuropsychiatric Genetics Group, Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
PLoS Genetics (Impact Factor: 8.17). 03/2012; 8(3):e1002548. DOI: 10.1371/journal.pgen.1002548
Source: PubMed

ABSTRACT More than 800 published genetic association studies have implicated dozens of potential risk loci in Parkinson's disease (PD). To facilitate the interpretation of these findings, we have created a dedicated online resource, PDGene, that comprehensively collects and meta-analyzes all published studies in the field. A systematic literature screen of -27,000 articles yielded 828 eligible articles from which relevant data were extracted. In addition, individual-level data from three publicly available genome-wide association studies (GWAS) were obtained and subjected to genotype imputation and analysis. Overall, we performed meta-analyses on more than seven million polymorphisms originating either from GWAS datasets and/or from smaller scale PD association studies. Meta-analyses on 147 SNPs were supplemented by unpublished GWAS data from up to 16,452 PD cases and 48,810 controls. Eleven loci showed genome-wide significant (P < 5 × 10(-8)) association with disease risk: BST1, CCDC62/HIP1R, DGKQ/GAK, GBA, LRRK2, MAPT, MCCC1/LAMP3, PARK16, SNCA, STK39, and SYT11/RAB25. In addition, we identified novel evidence for genome-wide significant association with a polymorphism in ITGA8 (rs7077361, OR 0.88, P  =  1.3 × 10(-8)). All meta-analysis results are freely available on a dedicated online database (, which is cross-linked with a customized track on the UCSC Genome Browser. Our study provides an exhaustive and up-to-date summary of the status of PD genetics research that can be readily scaled to include the results of future large-scale genetics projects, including next-generation sequencing studies.

Download full-text


Available from: Muin J Khoury, Aug 27, 2015
  • Source
    • "In PD, different PD susceptibility genes occur in early onset compared with late onset of PD [40] [41], and the MAPT gene did not independently influence the age of PD onset [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. í µí»¼-Synuclein (SNCA) and microtubule-associated protein tau (MAPT) are the two major genes independently, but not jointly, associated with susceptibility for Parkinson's disease (PD). The SNCA gene has recently been identified as a major modifier of age of PD onset. Whether MAPT gene synergistically influences age of onset of PD is unknown. Objective. To investigate independent and joint effects of MAPT and SNCA on PD onset age. Methods. 412 patients with PD were recruited from the Australian PD Research Network (123) and the Neurology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China (289). MAPT (rs17650901) tagging H1/H2 haplotype and SNCA (Rep1) were genotyped in the Australian cohort, and MAPT (rs242557, rs3744456) and SNCA (rs11931074, rs894278) were genotyped in the Chinese cohort. SPSS regression analysis was used to test genetic effects on age at onset of PD in each cohort. Results. SNCA polymorphisms associated with the onset age of PD in both populations. MAPT polymorphisms did not enhance such association in either entire cohort. Conclusion. This study suggests that, in both ethnic groups, SNCA gene variants influence the age at onset of PD and í µí»¼-synuclein plays a key role in the disease course of PD.
    BioMed Research International 08/2014; 2015. DOI:10.1155/2015/135674 · 2.71 Impact Factor
  • Source
    • "Importantly, the pathogenicity of some gene products of PD genes is also regulated by phosphorylation by upstream kinases, such as polo-like kinase 2 (PLK2), which phosphorylates the PD protein α-synuclein. There are also multiple kinases phosphorylating the microtubule associated protein tau (MAPT), a protein known to be involved in Alzheimer's disease and associated to PD in GWAS (Lill et al., 2012). Van Veen et al. review the cellular function and pathological role of ATP13A2 and related P-type transport ATPases in PD and other neurological disorders (Van Veen et al., 2014). "
    Frontiers in Molecular Neuroscience 07/2014; 7:71. DOI:10.3389/fnmol.2014.00071 · 4.08 Impact Factor
  • Source
    • "Genome-wide association studies have also implicated variations in the STK39 locus with PD. First identified through large-scale meta-analysis (Liu et al., 2011; Nalls et al., 2011), the association of STK39 SNPs with PD has been subsequently replicated in Asian and Caucasian populations (Lill et al., 2012; Sharma "
    [Show abstract] [Hide abstract]
    ABSTRACT: Substantial evidence implicates abnormal protein kinase function in various aspects of Parkinson's disease (PD) etiology. Elevated phosphorylation of the PD-defining pathological protein, α-synuclein, correlates with its aggregation and toxic accumulation in neurons, whilst genetic missense mutations in the kinases PTEN-induced putative kinase 1 and leucine-rich repeat kinase 2, increase susceptibility to PD. Experimental evidence also links kinases of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways, amongst others, to PD. Understanding how the levels or activities of these enzymes or their substrates change in brain tissue in relation to pathological states can provide insight into disease pathogenesis. Moreover, understanding when and where kinase dysfunction occurs is important as modulation of some of these signaling pathways can potentially lead to PD therapeutics. This review will summarize what is currently known in regard to the expression of these PD-implicated kinases in pathological human postmortem brain tissue.
    Frontiers in Molecular Neuroscience 06/2014; 7:57. DOI:10.3389/fnmol.2014.00057 · 4.08 Impact Factor
Show more